Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Call Transcript August 2, 2023
Editas Medicine, Inc. misses on earnings expectations. Reported EPS is $-0.78 EPS, expectations were $0.76.
Operator: Good morning and welcome to Editas Medicine’s Second Quarter Conference Call. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company’s request. I would now like to turn the call over to Cristi Barnett, Corporate...
